NORRIS PERNE & FRENCH LLP/MI

Position in LLY — ELI LILLY & Co

CIK 1092290 GRAND RAPIDS, MI

Position in LLY

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$712,461

+$381,344 QoQ

Shares Held

594

+65.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.11%

of 13F equity value

Holder Rank

#3,438

of 4,605 holders

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

NORRIS PERNE & FRENCH LLP/MI holds $41,974,464 across 6 Drug Manufacturers - General names. LLY ranks #4 (1.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	82,726	$21,009,922
2	MRK	Merck & Co., Inc.	145,117	$18,647,534
3	ABBV	AbbVie Inc.	3,997	$1,005,805
4	LLY	ELI LILLY & Co This page	594	$712,461
5	NVS	Novartis AG	2,516	$394,307
6	BMY	Bristol Myers Squibb Co	3,548	$204,435

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$712,461	594	+65.0%	Shares	Defined	2026-08-13
2026-03-31	$331,117	360	-56.2%	Shares	Sole	2026-04-22
2025-12-31	$882,312	821	+37.8%	Shares	Sole	2026-01-23
2025-09-30	$454,748	596	+27.9%	Shares	Sole	2025-10-17
2025-06-30	$363,260	466	0.0%	Shares	Sole	2025-07-17
2025-03-31	$384,874	466	+4.5%	Shares	Sole	2025-04-21
2024-12-31	$344,312	446	0.0%	Shares	Sole	2025-01-23
2024-09-30	$395,129	446	0.0%	Shares	Sole	2024-10-28
2024-06-30	$403,799	446	+9.3%	Shares	Sole	2024-07-24
2024-03-31	$317,407	408	-4.4%	Shares	Sole	2024-04-16
2023-09-30	$229,354	427	—	Shares	Sole	2023-10-18
No filing history on record for this holder in this stock.